Michael Girouard '09
Resident Physician in Internal Medicine/Primary Care
University of California, San Francisco
After St. Dom's, Michael studied chemistry at Université de Pierre et Marie Curie - Paris VI as an exchange student at Hamilton College, then transferred to Williams College to graduate with majors in chemistry and French literature.
He joined Massachusetts General Hospital as a Clinical Research Coordinator in the Cost-Effectivenews of Preventing AIDS Complications (CEPAC) Group.
In 2015 Michael began pursuing his Doctor of Medicine at Harvard Medical School. In 2017, he also started on an MBA degree at Harvard Business School, receiving both from Harvard in 2020.
Dr. Girouard's research in HIV and opioid use in LGBTQ populations are cited below along with other studies.
- Shortened Tuberculosis Treatment for People with HIV in South Africa: A Model-based Evaluation and Cost-effectiveness Analysis
- Understanding and treating opioid use disorders in lesbian, gay, bisexual, transgender and queer populations
- Addressing Opioid Use Disorder among LGBTQ Populations
- Survival benefits of antiretroviral therapy in Brazil: a model-based analysis
- The Cost-effectiveness and budget impact of 2-drug dolutegravir-lamivudine regimens for the treatment of HIV infection in the United States
- Cost-Effectiveness of Genotype Testing for Primary Resistance in Brazil